BIB — Proshares Ultra Nasdaq Biotech

The index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies. Under normal circumstances, the fund w...

The index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies. Under normal circumstances, the fund will obtain leveraged exposure to at least 80% of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified.

Industry

ETF

Exchange

NASD

First trade date

2010-04-06

The interactive platform loads with JavaScript. Research tools are for informational purposes.